Consistent with the ChIP-seq data showing overlapping peaks in human melanocytes and melanoma cells, we found that both BRD4 and BRD2 were bound to the Tyr and Tyrp1 promoters in Melb-a cells and that (+)JQ1 disrupted binding (Fig. 8a, b). Here, BRD4 is linked to melanoma.